Neurocrine Biosciences (NBIX) Prepaid Assets (2016 - 2025)
Historic Prepaid Assets for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $170.7 million.
- Neurocrine Biosciences' Prepaid Assets rose 16839.62% to $170.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $170.7 million, marking a year-over-year increase of 16839.62%. This contributed to the annual value of $170.7 million for FY2025, which is 16839.62% up from last year.
- As of Q4 2025, Neurocrine Biosciences' Prepaid Assets stood at $170.7 million, which was up 16839.62% from $178.1 million recorded in Q3 2025.
- Neurocrine Biosciences' Prepaid Assets' 5-year high stood at $178.1 million during Q3 2025, with a 5-year trough of $33.8 million in Q1 2021.
- Over the past 4 years, Neurocrine Biosciences' median Prepaid Assets value was $108.2 million (recorded in 2023), while the average stood at $102.5 million.
- As far as peak fluctuations go, Neurocrine Biosciences' Prepaid Assets crashed by 3496.93% in 2024, and later soared by 16839.62% in 2025.
- Neurocrine Biosciences' Prepaid Assets (Quarter) stood at $50.5 million in 2021, then surged by 93.66% to $97.8 million in 2023, then tumbled by 34.97% to $63.6 million in 2024, then skyrocketed by 168.4% to $170.7 million in 2025.
- Its Prepaid Assets was $170.7 million in Q4 2025, compared to $178.1 million in Q3 2025 and $120.7 million in Q2 2025.